Stocks and Investing Stocks and Investing
Mon, May 4, 2020

David Amsellem Maintained (AVDL) at Buy with Increased Target to $18 on, May 4th, 2020


Published on 2024-10-27 05:04:45 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $14 to $18 on, May 4th, 2020.

David has made no other calls on AVDL in the last 4 months.



There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $14 on, Friday, April 3rd, 2020
  • Paul Matteis of "Stifel" Initiated at Strong Buy and Held Target at $14 on, Thursday, March 12th, 2020
  • Francois Brisebois of "Craig-Hallum" Initiated at Strong Buy and Held Target at $15 on, Thursday, January 30th, 2020
Contributing Sources